Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity
- PMID: 36358622
- PMCID: PMC9657145
- DOI: 10.3390/cancers14215203
Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity
Abstract
CAM is used by about 40% of cancer patients in Western Countries, with peaks of 80% for breast cancer patients. Cancer patients use CAM to boost immune function, to control cancer symptoms and treatment-related side effects, and to improve health-related quality of life (HR-QoL) and survival. Unfortunately, self-prescription of natural remedies in cancer patients can lead to unexpected toxicities and can reduce the effectiveness of cancer therapy. Although CAM usually refers to all the "natural or organic" products/methods that are generally considered less toxic, there are concerns about drug interactions, especially in patients participating in clinical trials with experimental agents. Despite the claims of the promising and potential benefits made by prescribers, many CAMs lack clear scientific evidence of their safety and efficacy. Given the widespread use of CAM-both clearly declared and overt-in this review, we focused on the most important known data on the risk of interactions between biologics and oncology drugs with the goal of opening up CAM in accordance with the meaning of integrative medicine.
Keywords: alternative; cancer; chemotherapy; complementary; interactions; medicine; synergism.
Conflict of interest statement
The Authors declare no conflict of interest.
Figures




Similar articles
-
Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.J Ethnopharmacol. 2016 Jul 1;187:104-22. doi: 10.1016/j.jep.2016.04.038. Epub 2016 Apr 25. J Ethnopharmacol. 2016. PMID: 27125594
-
Trends in Complementary and Alternative Medicine Adoption by Cancer Patients.Curr Drug Saf. 2025 May 6. doi: 10.2174/0115748863376819250416092622. Online ahead of print. Curr Drug Saf. 2025. PMID: 40329732
-
Complementary, Alternative and Integrative Medicine for Childhood Atopic Dermatitis.Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):114-124. doi: 10.2174/1872213X11666171128142333. Recent Pat Inflamm Allergy Drug Discov. 2017. PMID: 29189188 Review.
-
Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Cancer Treat Rev. 2013. PMID: 23394826 Review.
-
Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies.Hematology Am Soc Hematol Educ Program. 2005:491-7. doi: 10.1182/asheducation-2005.1.491. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304425
Cited by
-
Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer.Int J Mol Sci. 2023 Jun 14;24(12):10120. doi: 10.3390/ijms241210120. Int J Mol Sci. 2023. PMID: 37373268 Free PMC article. Review.
-
Bridging the gap: attitudes and practices toward complementary and alternative medicine among oncology patients and healthcare professionals in Croatia.Front Psychol. 2025 Jan 29;16:1531111. doi: 10.3389/fpsyg.2025.1531111. eCollection 2025. Front Psychol. 2025. PMID: 39981396 Free PMC article.
-
Friedelin: Structure, Biosynthesis, Extraction, and Its Potential Health Impact.Molecules. 2023 Nov 24;28(23):7760. doi: 10.3390/molecules28237760. Molecules. 2023. PMID: 38067489 Free PMC article. Review.
-
Glutathione: Lights and Shadows in Cancer Patients.Biomedicines. 2023 Aug 8;11(8):2226. doi: 10.3390/biomedicines11082226. Biomedicines. 2023. PMID: 37626722 Free PMC article. Review.
-
An innovative approach to development of new pyrazolylquinolin-2-one hybrids as dual EGFR and BRAFV600E inhibitors.Mol Divers. 2025 Mar 8. doi: 10.1007/s11030-025-11127-4. Online ahead of print. Mol Divers. 2025. PMID: 40056327
References
-
- Collado-Borrell R., Escudero-Vilaplana V., Romero-Jiménez R., Iglesias-Peinado I., Herranz-Alonso A., Sanjurjo-Sáez M. Oral Antineoplastic Agent Interactions with Medicinal Plants and Food: An Issue to Take into Account. J. Cancer Res. Clin. Oncol. 2016;142:2319–2330. doi: 10.1007/s00432-016-2190-8. - DOI - PMC - PubMed
-
- Berretta M., Franceschi F., Quagliariello V., Montopoli M., Cazzavillan S., Rossi P., Zanello P.P. The Role of Integrative and Complementary Medicine in the Management of Breast Cancer Patients on Behalf of the Integrative Medicine Research Group (IMRG) Eur. Rev. Med. Pharmacol. Sci. 2022;26:947–956. doi: 10.26355/eurrev_202202_28004. - DOI - PubMed
-
- Berretta M., Morra A., Taibi R., Monari F., Maurea N., Ippolito M., Tirelli U., Fiorica F., Montella L., Facchini G., et al. Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature. Front. Pharmacol. 2022;13:867907. doi: 10.3389/fphar.2022.867907. - DOI - PMC - PubMed
-
- Complementary and Alternative Medicine (CAM)—NCI. [(accessed on 17 August 2022)]; Available online: https://www.cancer.gov/about-cancer/treatment/cam.
-
- Berretta M., Rinaldi L., Taibi R., Tralongo P., Fulvi A., Montesarchio V., Madeddu G., Magistri P., Bimonte S., Trovò M., et al. Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study. Front. Oncol. 2020;10:594. doi: 10.3389/fonc.2020.00594. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources